InvestorsPrism
  • Home
  • Indexes
    • All Indexes
    • Cannabis
    • EV
    • Gene Therapy
    • MedDevices
    • MedDiagnostics
    • Solar
    • Uranium
    • Vaccines & Cell Therapy
    • Web 3.0
  • Companies
  • Trending News
    • Latest
    • Markets
    • Finance
    • Economy
    • Technology
    • Earnings
    • Healthcare
    • Prism Daily
  • Equity Research
    • Login
    • Register
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Cannabis
    • EV
    • Gene Therapy
    • MedDevices
    • MedDiagnostics
    • Solar
    • Uranium
    • Vaccines & Cell Therapy
    • Web 3.0
  • Companies
  • Trending News
    • Latest
    • Markets
    • Finance
    • Economy
    • Technology
    • Earnings
    • Healthcare
    • Prism Daily
  • Equity Research
    • Login
    • Register
    • User Profile
    • Log Out

Home News Feeds Vaccines & Cell Therapy

Feed Category: Vaccines & Cell Therapy

January 29 at 10:27 pm

Sorrento Issues “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

Sorrento Therapeutics, Inc.SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a “Frequently Asked Questions” document under the “Investors”… [Read More]
January 29 at 9:55 pm

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

Sorrento Therapeutics, Inc.PALO ALTO, Calif., Jan. 29, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE,… [Read More]
January 27 at 4:41 pm

Novavax (NVAX) COVID Jab Aids Growth, Overdependence a Challenge (revised)

Though Novavax, Inc. NVAX is one of a handful of vaccine makers that has secured authorizations for its protein-based COVID-19 vaccine in the United States,… [Read More]
January 27 at 2:14 pm

Gaithersburg’s Novavax ‘prepared to deliver’ updated Covid-19 vaccine following FDA advisory panel vote

Gaithersburg’s Novavax ‘prepared to deliver’ updated Covid-19 vaccine following FDA advisory panel voteIn this article: Oops!Something went wrong.Please try again later.An FDA advisory committee voted… [Read More]
January 27 at 10:24 am

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna SlipIn this article: Oops!Something went wrong.Please try again later.Oops!Something went wrong.Please try again later.Oops!Something… [Read More]
January 27 at 9:37 am

3 Great Growth Stocks Down 20% or More to Buy Now

Three Motley Fool contributors were asked to identify great growth stocks down 20% or more to buy now. Here’s why they chose Beam Therapeutics (NASDAQ:… [Read More]
January 27 at 9:13 am

FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy

On Jan 26, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously recommended moving toward a uniform vaccine strain composition for all COVID-19… [Read More]
January 26 at 5:50 pm

Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Novavax (NVAX) closed at $10.98, marking a -1.17% move from the previous day. This change lagged the S&P 500’s 1.1%… [Read More]
January 26 at 4:11 pm

New Novavax CEO John Jacobs Takes The Helm — But Is NVAX Stock A Buy Today?

New Novavax CEO John Jacobs Takes The Helm — But Is NVAX Stock A Buy Today?In this article: Oops!Something went wrong.Please try again later.Is Novavax… [Read More]
January 26 at 2:25 pm

Novavax needs 6 months to produce annual COVID shots that match new variants

By Leroy LeoJan 26 (Reuters) – Novavax Inc said on Thursday it would require six months to produce a COVID-19 vaccine designed to match whichever… [Read More]
January 26 at 9:55 am

Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 103.22%: Read This Before Placing a Bet

Shares of Dynavax Technologies (DVAX) have gained 15% over the past four weeks to close the last trading session at $11.81, but there could still… [Read More]
January 26 at 7:31 am

Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe

Though Novavax, Inc. NVAX is one of a handful of vaccine makers that has secured authorizations for its protein-based COVID-19 vaccine in the United States,… [Read More]

Posts navigation

Page 1 Page 2 … Page 9 Next page
InvestorsPrism

Copyright © 2023 Investors Prism
All rights reserved

Company

  • About Us
  • Contact Us
  • Privacy Policy
  • Disclaimer

News

  • Latest
  • Markets
  • Finance
  • Economy
  • Technology
  • Earnings
  • Healthcare
  • Prism Daily

Indexes

  • Cannabis
  • EV
  • Gene Therapy
  • MedDevices
  • MedDiagnostics
  • Solar
  • Uranium
  • Vaccines & Cell Therapy
  • Web 3.0